Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ASS1P13 (Argininosuccinate synthetase 1 pseudogene 13) is classified as a pseudogene—a genomic DNA sequence similar to normal genes but non-functional; it does not encode a functional protein. ASS1P13 is one of several non-protein-coding pseudogenes related to the argininosuccinate synthetase 1 gene, and there is no evidence for a biological or disease-related role, therapeutic relevance, or drug interaction. Its only known function is as a genomic marker reflecting gene duplication events in evolution[5]. There is nothing misspelled or structurally incorrect about this entry, but it is not a molecular target of therapeutic or biological interest. The functional gene is "argininosuccinate synthase 1" (ASS1), not this pseudogene[5][2][3][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Argininosuccinate synthetase 1 pseudogene 13 (ASS1P13).